Results
Job offer: spin-off coach
We are looking for a technology transfer officer focused on spin-off coaching.Read the job description here . Send your CV and motivation letter to hugo.loosvelt@vub.be before February 28.
Read more
Share your expertise on alternative methods to animal testing
RE-Place is a scientific project coordinated by the VUB and Sciensano that aims to collect the available expertise on alternative methods to animal testing, also known as “New Approach Methodologies (NAMs)”, in one central database. Recently, an optimized version of the online to...
Read more
Nanobodies to target Parkinson's disease
Parkinson’s disease is the second most common neurodegenerative disorder, affecting more than 10 million people worldwide. This number is likely to increase as the population ages, and unfortunately there is no cure to date.
Read more
VUB spin-off Lavima develops new fertility treatment
Couples unable to get pregnant naturally often resort to In Vitro Fertilisation (IVF) to fulfil their desire to have children.
Read more
Confo Therapeutics doses first subjects in Phase 1 clinical trial
Confo Therapeutics, VIB-VUB spin-off and leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), announced that the first subjects have been dosed in the company’s Phase 1, first-in-human trial of their clinical candidate CFTX-1554.
Read more
European Research & Innovation Support 3.0 @VUB
The ERIS team of the VUB Vicerectorate Innovation & Industry Relations has launched its renewed strategy reinforced by a new team and textminer to better support its researchers looking for EU funding and opportunities for applied research! Check out the new webpages here
Read more
Precirix raises €80M in Series B to advance its pipeline of precision radiopharmaceuticals
VUB spin-off Precirix , a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today announces the closing of a €80M Series B financing round led by new investors INKEF Capital, Jeito Capital and Forbion as co-leads. The company's lead product...
Read more
Inter-university venture capital fund Qbic announces first close of new fund at €49M
Investing in spin-offs from world-class knowledge partners Qbic, an inter-university venture capital firm focusing on the transformation of technological breakthroughs into sustainable businesses, announces the first close of its third fund at €49M.
Read more
Helpdesk for AI professionals
Self-learning algorithms are increasingly a part of our lives. But what decisions can these algorithms make? A simple “computer says no” without transparency or objection?
Read more
FOR BUSINESSES
Read more